Hadley Phillips, DO
Ophthalmology · Elmwood Park, NJNPI 1629036306
Payments from drug & device makers
What this record shows
19 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 55.2% of the total. Reporting peaked in 2020 at $6,390 and has fallen 92.2% since, to $501 in 2025. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $58.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$6K
- Alcon$2K
- Sun Pharmaceutical Industries Inc.$902
- Johnson & Johnson Surgical Vision, Inc.$632
- AbbVie$347
- Glaukos Corporation$290
- plus $965 from 13 others
What the payments were for
- Food & beverage$4,76645%
- Gifts$5,87455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 2 | $5,874 |
| Alcon | 24 | $1,630 |
| Sun Pharmaceutical Industries Inc. | 59 | $902 |
| Johnson & Johnson Surgical Vision, Inc. | 26 | $632 |
| AbbVie(2 entities) | 23 | $347 |
| Glaukos Corporation | 2 | $290 |
| Ocular Therapeutix, Inc. | 17 | $273 |
| Bausch & Lomb Americas Inc. | 6 | $171 |
| Harrow Eye, LLC | 2 | $138 |
| Biotissue Holdings Inc. | 6 | $126 |
| Oyster Point Pharma, Inc. | 3 | $47 |
| Novartis | 3 | $41 |
| Dompe US, Inc. | 3 | $41 |
| Eyevance Pharmaceuticals LLC | 2 | $35 |
| NEW World Medical,inc. | 1 | $24 |
| Ivantis, Inc | 1 | $20 |
| Tarsus Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLARUS$5,472
- Humphrey HFA$403
- AcrySof IQ PanOptix$258
- AcrySof IQ VIVITY$208
- iDose$166
- iStent inject Trabecular Micro-Bypass Stent System$124
- Tecnis IOL$113
- Clareon$110
How this compares
$10,640 in reported general payments places this provider in the 90th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 35 | $36,855 |
| Prednisolone Acetate | 380 | $17,692 |
| XiidraLifitegrast | 12 | $13,988 |
| Ketorolac Tromethamine | 26 | $1,045 |
| Latanoprost | 15 | $271 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $347 | $36,85535 claims |
| Bausch & Lomb Americas Inc.Xiidra | $171 | $13,98812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Elmwood Park
- Jacqueline GabayElmwood Park$8K
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
- Robert FechtnerNewark$324K
- Rajen DesaiFreehold$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.